
Regulatory29 Jul 2026, 08:21 pm
Aequs: Monitoring Agency Report confirms no deviation in IPO proceeds
AI Summary
Aequs Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, concerning the utilization of proceeds from its Pre-Initial Public Offer Placement and Initial Public Offer. The report, issued by CARE Ratings Limited, confirms that there is no material deviation in the utilization of the Rs. 144.0 crore raised through the Pre-IPO placement from the stated objects of the issue. This report, reviewed and taken on record by the company's Audit Committee and Board of Directors, ensures compliance with SEBI regulations and will be made available on the company's website.
Key Highlights
- Aequs submitted Monitoring Agency Report for Q1 FY27.
- CARE Ratings confirmed no material deviation in IPO proceeds use.
- Report covers Rs. 144.0 crore raised via Pre-IPO placement.
- Audit Committee and Board reviewed and approved the report.
- Ensures regulatory compliance and transparency in fund utilization.
Price Impact
More from AEQUS